Delayed
Canadian Securities Exchange
01:05:54 16/05/2024 am IST
|
5-day change
|
1st Jan Change
|
0.07
CAD
|
0.00%
|
|
-6.67%
|
+40.00%
|
Fiscal Period: October |
2020
|
2021
|
2022
|
---|
Capitalization
1 |
29.91
|
34.11
|
22.31
|
Enterprise Value (EV)
1 |
27.48
|
33.52
|
22.16
|
P/E ratio
|
-10.1
x
|
-4.75
x
|
-1.72
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
EV / FCF
|
-45,23,22,377
x
|
-1,23,88,775
x
|
-3,01,22,929
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
Price to Book
|
3.25
x
|
4.17
x
|
-28.8
x
|
Nbr of stocks (in thousands)
|
71,203
|
92,187
|
1,08,813
|
Reference price
2 |
0.4200
|
0.3700
|
0.2050
|
Announcement Date
|
01/03/21
|
28/02/22
|
03/03/23
|
Fiscal Period: October |
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.1833
|
-1.009
|
-5.979
|
-3.803
|
Operating Margin
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.2169
|
-1.103
|
-6.458
|
-11.73
|
Net income
1 |
-0.2301
|
-1.174
|
-6.458
|
-11.73
|
Net margin
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.0222
|
-0.0416
|
-0.0779
|
-0.1194
|
Free Cash Flow
|
-
|
-0.0608
|
-2.705
|
-0.7358
|
FCF margin
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
01/03/21
|
01/03/21
|
28/02/22
|
03/03/23
|
Fiscal Period: October |
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
Net Cash position
1 |
0.23
|
2.42
|
0.59
|
0.14
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-0.06
|
-2.71
|
-0.74
|
ROE (net income / shareholders' equity)
|
-
|
-22.6%
|
-72.8%
|
-317%
|
ROA (Net income/ Total Assets)
|
-
|
-11.7%
|
-39.4%
|
-50.7%
|
Assets
1 |
-
|
10.02
|
16.38
|
23.11
|
Book Value Per Share
2 |
0.0200
|
0.1300
|
0.0900
|
-0.0100
|
Cash Flow per Share
2 |
0.0200
|
0.0300
|
0.0100
|
0
|
Capex
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
01/03/21
|
01/03/21
|
28/02/22
|
03/03/23
|
|
1st Jan change
|
Capi.
|
---|
| +40.00% | 1.08Cr | | +6.68% | 11TCr | | +10.97% | 11TCr | | +0.84% | 2.23TCr | | -12.58% | 2.22TCr | | -5.57% | 1.94TCr | | -37.85% | 1.79TCr | | -6.41% | 1.72TCr | | +7.57% | 1.43TCr | | +34.56% | 1.25TCr |
Bio Therapeutic Drugs
|